TickerFacts.

GRAIL, Inc. (GRAL): EPS (Basic)

Annual figures by period end, from SEC filings.

-$11.11
Year ended 2025-12-31
2023-01-01: -$173.892023-12-31: -$47.212024-12-31: -$63.542025-12-31: -$11.11-$11.11
2023-01-01 EPS (Basic) (USD per share) 2025-12-31
Period endedEPS (Basic)Change YoYSource filing
2025-12-31-$11.11n/m2026-03-12, From 2025-01-01
2024-12-31-$63.54n/m2026-03-12, From 2024-01-01
2023-12-31-$47.21n/a2026-03-12, From 2023-01-01
2023-01-01, Fiscal 2022-$173.89n/a2025-03-05, From 2022-01-03

EPS (Basic) at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
GRAIL, Inc. (GRAL)2025-12-31-$11.11n/m
Biodesix Inc (BDSX)2025-12-31-$4.67n/m
BillionToOne, Inc. (BLLN)2025-12-31$0.18n/m
Personalis, Inc. (PSNL)2025-12-31-$0.91n/m
Exagen Inc. (XGN)2025-12-31-$0.93n/m
Castle Biosciences Inc (CSTL)2025-12-31-$0.83n/m
CareDx, Inc. (CDNA)2025-12-31-$0.40n/m
Veracyte, Inc. (VCYT)2025-12-31$0.84+162.5%
American Shared Hospital Services (AMS)2025-12-31-$0.23n/m

Compare GRAL, BDSX, BLLN, PSNL side by side · Screen every company in Services-Medical Laboratories ↗